Clinical trial Recruiting at 1 site Observational Ages 16 and up Women only

Understanding postpartum pulmonary artery pressure in women with preeclampsia and antiphospholipid syndrome

Official title: Association Between Preeclampsia, Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure, Systemic Arterial Pressure and Cardiovascular Function.

Run by Insel Gruppe AG, University Hospital Bern · NCT05679206 · Data updated 2026-11-12

This study looks at the heart health of women who had high blood pressure during pregnancy and also have a specific blood condition, to see how these issues affect them after childbirth.

More Pulmonary Hypertension trials

Quick facts

Study typeObservational
Ages16 Years and up
SexWomen only
Enrollment900 (estimated)
SponsorInsel Gruppe AG, University Hospital Bern
Academic / other
Locations1 site (Bern)
StatusRecruiting
StartedDecember 20, 2022
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedMay 9, 2024
Trial IDNCT05679206 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women over 16 years old who have suffered from preeclampsia during pregnancy.

Probably not a fit

Patients under 16 years old or those with incomplete or ambiguous data regarding their eligibility will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate postpartum pulmonary artery pressure in women who experienced preeclampsia during pregnancy, particularly focusing on those with antiphospholipid syndrome. Participants will be monitored for up to three years after childbirth to assess the long-term cardiovascular effects of these conditions. The study involves clinical examinations, echocardiography, blood sampling, and 24-hour ambulatory blood pressure monitoring to gather comprehensive data on the participants' health. This research represents a unique cohort in Switzerland, providing valuable insights into the intersection of these serious pregnancy complications and their long-term impacts.

Why it matters

Potential benefit: If successful, this study could lead to better understanding and management of cardiovascular risks in women who have experienced preeclampsia and antiphospholipid syndrome.

How similar studies have gone: While this specific approach is novel in Switzerland, similar studies have indicated the importance of monitoring cardiovascular health in women with a history of preeclampsia.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age: \> 16 years.
* Consent or waiver of consent according Chapter 9
* Preeclampsia

Defined as:

• New onset hypertension (blood pressure \>140/90mmHg on multiple occasions after 20 weeks of gestation)

In combination with new onset of 1 or more of the following:

* Proteinuria (urine protein \>300mg /24h or 2+ or higher in dipstick on multiple occasions)
* Platelet count \<100,000/microL,
* Serum creatinine \>97.2 micromol/L,
* Liver transaminases at least twice the upper limit of the normal concentrations,
* Pulmonary edema,
* New-onset and persistent headache,
* Visual symptoms. -Postnatal follow up at the obstetrical and cardiology clinic, Inselspital Bern, Switzerland.

Exclusion Criteria:

* Age: \< 16 years
* Incomplete or ambiguous data: if data confirming the eligibility criteria or data to analyze the primary endpoint is not fully available or despite efforts assessed as significantly ambiguous, the data set will be excluded from analyses, since no analysis is possible

Where it's running

  • Inselspital
    Bern, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.